陈丽萍. 小剂量美罗华联合重组人血小板生成素治疗难治性特发性血小板减少性紫癜的护理[J]. 实用临床医药杂志, 2016, (8): 47-49,60. DOI: 10.7619/jcmp.201608015
引用本文: 陈丽萍. 小剂量美罗华联合重组人血小板生成素治疗难治性特发性血小板减少性紫癜的护理[J]. 实用临床医药杂志, 2016, (8): 47-49,60. DOI: 10.7619/jcmp.201608015
CHEN Liping. Nursing for patients with refractory idiopathic thrombocytopenic purpura by combination treatment of small dose of rituximab and recombinant human thrombopoietin[J]. Journal of Clinical Medicine in Practice, 2016, (8): 47-49,60. DOI: 10.7619/jcmp.201608015
Citation: CHEN Liping. Nursing for patients with refractory idiopathic thrombocytopenic purpura by combination treatment of small dose of rituximab and recombinant human thrombopoietin[J]. Journal of Clinical Medicine in Practice, 2016, (8): 47-49,60. DOI: 10.7619/jcmp.201608015

小剂量美罗华联合重组人血小板生成素治疗难治性特发性血小板减少性紫癜的护理

Nursing for patients with refractory idiopathic thrombocytopenic purpura by combination treatment of small dose of rituximab and recombinant human thrombopoietin

  • 摘要: 目的 探讨小剂量美罗华联合重组人血小板生成素(rhTPO)治疗难治性特发性血小板减少性紫癜(ITP)的疗效及其护理.方法 对诊断为难治性ITP的4例患者采用小剂量美罗华联合rhTPO治疗,治疗过程中实施有效的心理护理,严格规范药液的保管、配置及输注,积极预防和处理药物不良反应,并对副作用进行严密观察和护理.结果 4例患者中,1例获完全反应(CR),3例获部分反应(PR),发热1例、肝功能异常1例,所有患者均顺利完成治疗.结论 小剂量美罗华联合rhTPO为难治性ITP的治疗提供了新途径,是一种安全有效的治疗方法,精心的护理能有效预防药物的毒副作用,保证治疗效果.

     

/

返回文章
返回